{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:02:23Z","timestamp":1766023343771,"version":"3.48.0"},"reference-count":51,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Exp Immunol"],"DOI":"10.62347\/huzj9149","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T23:32:58Z","timestamp":1751326378000},"page":"157-166","source":"Crossref","is-referenced-by-count":0,"title":["Impact of lactobacillus probiotics on vaccine response in diabetic rats: modulation of inflammatory cytokines"],"prefix":"10.62347","volume":"14","author":[{"given":"Jehan","family":"Alrahimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.3390\/ijms21207785","article-title":"Lymph node stromal cells: mapmakers of T cell immunity","volume":"21","author":"Harl&#xE9","year":"2020","unstructured":"Harlé G, Kowalski C, Garnier L and Hugues S. Lymph node stromal cells: mapmakers of T cell immunity. Int J Mol Sci 2020; 21: 7785.","journal-title":"Int J Mol Sci"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fimmu.2019.00360","article-title":"Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis","volume":"10","author":"Gaudino","year":"2019","unstructured":"Gaudino SJ and Kumar P. Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis. Front Immunol 2019; 10: 360.","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"621931","DOI":"10.3389\/fimmu.2020.621931","article-title":"Interleukin-1 as innate mediator of T cell immunity","volume":"11","author":"Den Eeckhout B","year":"2021","unstructured":"Van Den Eeckhout B, Tavernier J and Gerlo S. Interleukin-1 as innate mediator of T cell immunity. Front Immunol 2021; 11: 621931.","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","unstructured":"Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, Lee SR and Yang SH. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int J Mol Sci 2021; 22: 2719.","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/tropicalmed9010013","article-title":"Pro-inflammatory and anti-inflammatory interleukins in infectious diseases: a comprehensive review","volume":"9","author":"Al-Qahtani","year":"2024","unstructured":"Al-Qahtani AA, Alhamlan FS and Al-Qahtani AA. Pro-inflammatory and anti-inflammatory interleukins in infectious diseases: a comprehensive review. Trop Med Infect Dis 2024; 9: 13.","journal-title":"Trop Med Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"648408","DOI":"10.3389\/fimmu.2021.648408","article-title":"Low-Dose IL-2 therapy in autoimmune and rheumatic diseases","volume":"12","author":"Gra&#xDF","year":"2021","unstructured":"Graßhoff H, Comdühr S, Monne LR, Müller A, Lamprecht P, Riemekasten G and Humrich JY. Low-Dose IL-2 therapy in autoimmune and rheumatic diseases. Front Immunol 2021; 12: 648408.","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM and Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity 2022; 55: 31-55.","journal-title":"Immunity"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3390\/vaccines11071247","article-title":"Impact of obesity and diabetes in pregnant women on their immunity and vaccination","volume":"11","author":"Wierzchowska-Opoka M","year":"2023","unstructured":"Wierzchowska-Opoka M, Grunwald A, Rekowska AK, Łomża A, Mekler J, Santiago M, Kabała Z, Kimber-Trojnar Ż and Leszczyńska-Gorzelak B. Impact of obesity and diabetes in pregnant women on their immunity and vaccination. Vaccines (Basel) 2023; 11: 1247.","journal-title":"Vaccines (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells12010184","article-title":"Probiotics mechanism of action on immune cells and beneficial effects on human health","volume":"12","author":"Mazziotta","year":"2023","unstructured":"Mazziotta C, Tognon M, Martini F, Torreggiani E and Rotondo JC. Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells 2023; 12: 184.","journal-title":"Cells"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/nu15020269","article-title":"Immunomodulation of b lymphocytes by prebiotics, probiotics and synbiotics: application in pathologies","volume":"15","author":"Rousseaux","year":"2023","unstructured":"Rousseaux A, Brosseau C and Bodinier M. Immunomodulation of b lymphocytes by prebiotics, probiotics and synbiotics: application in pathologies. Nutrients 2023; 15: 269.","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.3390\/foods10123131","article-title":"Lactic acid bacteria as antimicrobial agents: food safety and microbial food spoilage prevention","volume":"10","author":"Ibrahim","year":"2021","unstructured":"Ibrahim SA, Ayivi RD, Zimmerman T, Siddiqui SA, Altemimi AB, Fidan H, Esatbeyoglu T and Bakhshayesh RV. Lactic acid bacteria as antimicrobial agents: food safety and microbial food spoilage prevention. Foods 2021; 10: 3131.","journal-title":"Foods"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"940454","DOI":"10.3389\/fmed.2022.940454","article-title":"Probiotics and probiotic-based vaccines: a novel approach for improving vaccine efficacy","volume":"9","author":"Kazemifard","year":"2022","unstructured":"Kazemifard N, Dehkohneh A and Baradaran Ghavami S. Probiotics and probiotic-based vaccines: a novel approach for improving vaccine efficacy. Front Med (Lausanne) 2022; 9: 940454.","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0733-8619(05)70162-6","article-title":"Overview of acute and chronic meningitis","volume":"17","author":"Coyle","year":"1999","unstructured":"Coyle PK. Overview of acute and chronic meningitis. Neurol Clin 1999; 17: 691-710.","journal-title":"Neurol Clin"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","unstructured":"Mbaeyi SA, Bozio CH, Duffy J, Rubin LG, Hariri S, Stephens DS and MacNeil JR. Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020. MMWR Recomm Rep 2020; 69: 1-41.","journal-title":"MMWR Recomm Rep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpam.2015.02.001","article-title":"Adolescent immunization - protecting youth and preparing them for a healthy future","volume":"2","author":"Langley","year":"2015","unstructured":"Langley JM. Adolescent immunization - protecting youth and preparing them for a healthy future. Int J Pediatr Adolesc Med 2015; 2: 1-6.","journal-title":"Int J Pediatr Adolesc Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/21645515.2017.1412020","article-title":"Vaccine prevention of meningococcal disease in Africa: major advances, remaining challenges","volume":"14","author":"Mustapha","year":"2018","unstructured":"Mustapha MM and Harrison LH. Vaccine prevention of meningococcal disease in Africa: major advances, remaining challenges. Hum Vaccin Immunother 2018; 14: 1107-1115.","journal-title":"Hum Vaccin Immunother"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Asamoah-Boaheng M, Goldfarb D, Prusinkiewicz MA, Golding L, Karim ME, Barakauskas V, Wall N, Jassem AN, Marquez AC, MacDonald C, O’Brien SF, Lavoie P and Grunau B. Determining the optimal SARS-CoV-2 mRNA vaccine dosing interval for maximum immunogenicity. Cureus 2023; 15: e34465.","DOI":"10.7759\/cureus.34465"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"662218","DOI":"10.3389\/fimmu.2021.662218","article-title":"Precision vaccine development: cues from natural immunity","volume":"12","author":"Barman","year":"2021","unstructured":"Barman S, Soni D, Brook B, Nanishi E and Dowling DJ. Precision vaccine development: cues from natural immunity. Front Immunol 2021; 12: 662218.","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41541-020-00238-8","article-title":"Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines","volume":"5","author":"Lofano","year":"2020","unstructured":"Lofano G, Mallett CP, Bertholet S and O’Hagan DT. Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines. NPJ Vaccines 2020; 5: 88.","journal-title":"NPJ Vaccines"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/14760584.2019.1604231","article-title":"Selection of adjuvants for vaccines targeting specific pathogens","volume":"18","author":"Sarkar","year":"2019","unstructured":"Sarkar I, Garg R and van Drunen Littel-van den Hurk S. Selection of adjuvants for vaccines targeting specific pathogens. Expert Rev Vaccines 2019; 18: 505-521.","journal-title":"Expert Rev Vaccines"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"738","DOI":"10.4239\/wjd.v13.i9.738","article-title":"Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy","volume":"13","author":"Vasilev","year":"2022","unstructured":"Vasilev G, Kabakchieva P, Miteva D, Batselova H and Velikova T. Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy. World J Diabetes 2022; 13: 738-751.","journal-title":"World J Diabetes"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/pathophysiology30020014","article-title":"Challenges in the vaccination of the elderly and strategies for improvement","volume":"30","author":"Soegiarto","year":"2023","unstructured":"Soegiarto G and Purnomosari D. Challenges in the vaccination of the elderly and strategies for improvement. Pathophysiology 2023; 30: 155-173.","journal-title":"Pathophysiology"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Tuckerman J, Kaufman J and Danchin M. Effective approaches to combat vaccine hesitancy. Pediatr Infect Dis J 2022; 41: e243-e245.","DOI":"10.1097\/INF.0000000000003499"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/vaccines11030696","article-title":"Immune response related to lymphadenopathy post COVID-19 vaccination","volume":"11","author":"TC","year":"2023","unstructured":"Ho TC, Shen DH, Chang CC, Chan HP, Chuang KP, Yuan CH, Chen CN, Yang MH and Tyan YC. Immune response related to lymphadenopathy post COVID-19 vaccination. Vaccines (Basel) 2023; 11: 696.","journal-title":"Vaccines (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Liu LL, Zhao H, Ma TF, Ge F, Chen CS and Zhang YP. Identification of valid reference genes for the normalization of RT-qPCR expression studies in human breast cancer cell lines treated with and without transient transfection. PLoS One 2015; 10: e0117058.","DOI":"10.1371\/journal.pone.0117058"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1161521","DOI":"10.3389\/fendo.2023.1161521","article-title":"Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments","volume":"14","author":"Ruze","year":"2023","unstructured":"Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R, Yin X and Xu Q. Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front Endocrinol (Lausanne) 2023; 14: 1161521.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"100076","DOI":"10.1016\/j.obpill.2023.100076","article-title":"Why does type 2 diabetes mellitus impair weight reduction in patients with obesity? A review","volume":"7","author":"Bays","year":"2023","unstructured":"Bays HE. Why does type 2 diabetes mellitus impair weight reduction in patients with obesity? A review. Obes Pillars 2023; 7: 100076.","journal-title":"Obes Pillars"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","unstructured":"Foretz M, Guigas B and Viollet B. Metformin: update on mechanisms of action and repurposing potential. Nat Rev Endocrinol 2023; 19: 460-476.","journal-title":"Nat Rev Endocrinol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/obesities3010006","article-title":"Disrupting the mood and obesity cycle: the potential role of metformin","volume":"3","author":"Doan","year":"2023","unstructured":"Doan SN, Patel SK, Xie B, Nelson RA and Yee LD. Disrupting the mood and obesity cycle: the potential role of metformin. Obesities 2023; 3: 59-75.","journal-title":"Obesities"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.3390\/ijms22094458","article-title":"In sickness and in health: the immunological roles of the lymphatic system","volume":"22","author":"Johnson","year":"2021","unstructured":"Johnson LA. In sickness and in health: the immunological roles of the lymphatic system. Int J Mol Sci 2021; 22: 4458.","journal-title":"Int J Mol Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/dmrr.500","article-title":"Lymphatic system changes in diabetes mellitus: role of insulin and hyperglycemia","volume":"21","author":"Moriguchi","year":"2005","unstructured":"Moriguchi P, Sannomiya P, Lara PF, Oliveira-Filho RM, Greco KV and Sudo-Hayashi LS. Lymphatic system changes in diabetes mellitus: role of insulin and hyperglycemia. Diabetes Metab Res Rev 2005; 21: 150-7.","journal-title":"Diabetes Metab Res Rev"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases: molecular mechanisms and therapeutic strategies","volume":"8","author":"Li","year":"2023","unstructured":"Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, Huang L and Liu Y. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Ther 2023; 8: 152.","journal-title":"Signal Transduct Target Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/vaccines12040396","article-title":"Vaccines induce homeostatic immunity, generating several secondary benefits","volume":"12","author":"Arunachalam","year":"2024","unstructured":"Arunachalam AB. Vaccines induce homeostatic immunity, generating several secondary benefits. Vaccines (Basel) 2024; 12: 396.","journal-title":"Vaccines (Basel)"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/TP.0000000000004057","article-title":"Higher proinflammatory cytokines are associated with increased antibody titer after a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients","volume":"106","author":"Karaba","year":"2022","unstructured":"Karaba AH, Zhu X, Benner SE, Akinde O, Eby Y, Wang KH, Saraf S, Garonzik-Wang JM, Klein SL, Bailey JR, Cox AL, Blankson JN, Durand CM, Segev DL, Werbel WA and Tobian AAR. Higher proinflammatory cytokines are associated with increased antibody titer after a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients. Transplantation 2022; 106: 835-841.","journal-title":"Transplantation"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41420-023-01666-w","article-title":"The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects","volume":"9","author":"Li","year":"2023","unstructured":"Li C, Peng K, Xiao S, Long Y and Yu Q. The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects. Cell Death Discov 2023; 9: 361.","journal-title":"Cell Death Discov"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41577-021-00554-7","article-title":"Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms","volume":"22","author":"Lynn","year":"2022","unstructured":"Lynn DJ, Benson SC, Lynn MA and Pulendran B. Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms. Nat Rev Immunol 2022; 22: 33-46.","journal-title":"Nat Rev Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3390\/nu16091350","article-title":"The influence of probiotic lactobacilli on COVID-19 and the microbiota","volume":"16","author":"CR","year":"2024","unstructured":"Taufer CR, da Silva J and Rampelotto PH. The influence of probiotic lactobacilli on COVID-19 and the microbiota. Nutrients 2024; 16: 1350.","journal-title":"Nutrients"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"770861","DOI":"10.3389\/fphar.2021.770861","article-title":"Effects of probiotic supplementation on inflammatory markers and glucose homeostasis in adults with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Ding","year":"2021","unstructured":"Ding LN, Ding WY, Ning J, Wang Y, Yan Y and Wang ZB. Effects of probiotic supplementation on inflammatory markers and glucose homeostasis in adults with type 2 diabetes mellitus: a systematic review and meta-analysis. Front Pharmacol 2021; 12: 770861.","journal-title":"Front Pharmacol"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"El Hadad S, Zakareya A, Al-Hejin A, Aldahlawi A and Alharbi M. Sustaining exposure to high concentrations of bifidobacteria inhibits gene expression of Mouse’s mucosal immunity. Heliyon 2019; 5: e02866.","DOI":"10.1016\/j.heliyon.2019.e02866"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3390\/nu15092217","article-title":"Beta cell dysfunction in youth- and adult-onset type 2 diabetes: an extensive narrative review with a special focus on the role of nutrients","volume":"15","author":"Serbis","year":"2023","unstructured":"Serbis A, Giapros V, Tsamis K, Balomenou F, Galli-Tsinopoulou A and Siomou E. Beta cell dysfunction in youth- and adult-onset type 2 diabetes: an extensive narrative review with a special focus on the role of nutrients. Nutrients 2023; 15: 2217.","journal-title":"Nutrients"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/v13061109","article-title":"The nature of immune responses to influenza vaccination in high-risk populations","volume":"13","author":"Wiggins","year":"2021","unstructured":"Wiggins KB, Smith MA and Schultz-Cherry S. The nature of immune responses to influenza vaccination in high-risk populations. Viruses 2021; 13: 1109.","journal-title":"Viruses"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Ali A, Shaheen S, Imran MZ, Memon Z, Zahid N, Ahmad F and Hameed A. Modulation of altered immune parameters IL-2 and TNF-α in diabetic animal models: a therapeutic insinuation of metformin beyond diabetes. Cureus 2023; 15: e45216.","DOI":"10.7759\/cureus.45216"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"152304","DOI":"10.1016\/j.imbio.2022.152304","article-title":"CD4 and IL-2 mediated NK cell responses after COVID-19 infection and mRNA vaccination in adults","volume":"228","author":"Alhajjat","year":"2023","unstructured":"Alhajjat AM, Redden CR, Langereis M, Papastefan ST, Ito JAS, Ott KC, Turner LE, Kang HK and Shaaban AF. CD4 and IL-2 mediated NK cell responses after COVID-19 infection and mRNA vaccination in adults. Immunobiology 2023; 228: 152304.","journal-title":"Immunobiology"},{"key":"ref43","unstructured":"Overwijk WW, Theoret MR and Restifo NP. The future of interleukin-2: enhancing therapeutic anticancer vaccines. Cancer J Sci Am 2000; 6 Suppl 1: S76-80."},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Berbudi A, Rahmadika N, Tjahjadi AI and Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev 2020; 16: 442-449.","DOI":"10.2174\/1573399815666191024085838"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2147\/JIR.S344393","article-title":"Low-Dose Interleukin-2 altered gut microbiota and ameliorated collagen-induced arthritis","volume":"15","author":"Li","year":"2022","unstructured":"Li N, Li X, Su R, Wu R, Niu HQ, Luo J, Gao C, Li X and Wang C. Low-Dose Interleukin-2 altered gut microbiota and ameliorated collagen-induced arthritis. J Inflamm Res 2022; 15: 1365-1379.","journal-title":"J Inflamm Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"7324","DOI":"10.1038\/s41467-022-34162-3","article-title":"Low-dose IL-2 reduces IL-21(+) T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes","volume":"13","author":"Zhang","year":"2022","unstructured":"Zhang JY, Hamey F, Trzupek D, Mickunas M, Lee M, Godfrey L, Yang JHM, Pekalski ML, Kennet J, Waldron-Lynch F, Evans ML, Tree TIM, Wicker LS, Todd JA and Ferreira RC. Low-dose IL-2 reduces IL-21(+) T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes. Nat Commun 2022; 13: 7324.","journal-title":"Nat Commun"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"153712","DOI":"10.1016\/j.phymed.2021.153712","article-title":"Cascade of immune mechanism and consequences of inflammatory disorders","volume":"91","author":"Megha","year":"2021","unstructured":"Megha KB, Joseph X, Akhil V and Mohanan PV. Cascade of immune mechanism and consequences of inflammatory disorders. Phytomedicine 2021; 91: 153712.","journal-title":"Phytomedicine"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.3390\/ijms22147644","article-title":"Diabetes mellitus and its metabolic complications: the role of adipose tissues","volume":"22","author":"Dilworth","year":"2021","unstructured":"Dilworth L, Facey A and Omoruyi F. Diabetes mellitus and its metabolic complications: the role of adipose tissues. Int J Mol Sci 2021; 22: 7644.","journal-title":"Int J Mol Sci"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1216321","DOI":"10.3389\/fimmu.2023.1216321","article-title":"Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes","volume":"14","author":"Nirenjen","year":"2023","unstructured":"Nirenjen S, Narayanan J, Tamilanban T, Subramaniyan V, Chitra V, Fuloria NK, Wong LS, Ramachawolran G, Sekar M, Gupta G, Fuloria S, Chinni SV and Selvaraj S. Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes. Front Immunol 2023; 14: 1216321.","journal-title":"Front Immunol"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Shi L, Sheng J, Chen G, Zhu P, Shi C, Li B, Park C, Wang J, Zhang B, Liu Z and Yang X. Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance. J Immunother Cancer 2020; 8: e000973.","DOI":"10.1136\/jitc-2020-000973"}],"container-title":["American Journal of Clinical and Experimental Immunology"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcei\/14\/3\/ajcei0162826.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:29Z","timestamp":1766023049000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcei\/14\/3\/ajcei0162826.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/huzj9149","relation":{},"ISSN":["2164-7712"],"issn-type":[{"type":"electronic","value":"2164-7712"}],"subject":[],"published":{"date-parts":[[2025]]}}}